We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

115 hedge funds and large institutions have $455M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,500% more call options, than puts

Call options by funds: $66K | Put options by funds: $1K

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

6% more funds holding

Funds holding: 109 → 115 (+6)

2% more capital invested

Capital invested by funds: $446M → $455M (+$9.47M)

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

Holders
115
Holders Change
+6
Holders Change %
+5.5%
% of All Funds
1.83%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
19
Increased
34
Reduced
37
Closed
13
Calls
$66K
Puts
$1K
Net Calls
+$65K
Net Calls Change
+$65K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$17.4M
2
BI
BVF Inc
California
+$10.3M
3
PC
Pier Capital
Connecticut
+$6.4M
4
GPP
Great Point Partners
Connecticut
+$6.24M
5
RCMNY
Rubric Capital Management (New York)
New York
+$6.07M

Top Sellers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
-$19.2M
2
PHS
PFM Health Sciences
California
-$10.6M
3
State Street
State Street
Massachusetts
-$8.64M
4
PA
Perceptive Advisors
New York
-$3.65M
5
Millennium Management
Millennium Management
New York
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
76
Janus Henderson Group
United Kingdom
$215K +$116K +15,616 +112%
DU
77
Delphia (USA)
Ontario, Canada
$210K +$110K +14,878 +106%
FWP
78
Firethorn Wealth Partners
Georgia
$207K -$63.2K -8,525 -24%
XT
79
XTX Topco
Cayman Islands
$183K +$186K +25,128 New
Principal Financial Group
80
Principal Financial Group
Iowa
$182K -$12.3K -1,663 -6%
BFM
81
Boothbay Fund Management
New York
$177K – – –
American Century Companies
82
American Century Companies
Missouri
$155K +$70.1K +9,446 +73%
AIMCA
83
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$153K -$39.5K -5,326 -20%
FRM
84
Fox Run Management
Connecticut
$151K +$154K +20,744 New
Teacher Retirement System of Texas
85
Teacher Retirement System of Texas
Texas
$142K +$4.91K +662 +4%
E
86
Ergoteles
New York
$141K +$144K +19,400 New
Verition Fund Management
87
Verition Fund Management
Connecticut
$137K +$140K +18,883 New
CSS
88
Cubist Systematic Strategies
Connecticut
$137K -$259K -34,861 -65%
UBS AM
89
UBS AM
Illinois
$135K -$135K -18,200 -50%
ASRS
90
Arizona State Retirement System
Arizona
$134K +$5.59K +753 +4%
JMPWA
91
JP Morgan Private Wealth Advisors
California
$109K +$111K +15,000 New
VEA
92
Virtus ETF Advisers
New York
$108K -$42.5K -5,727 -28%
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$102K – – –
PIC
94
Portland Investment Counsel
Ontario, Canada
$99K – – –
RJFSA
95
Raymond James Financial Services Advisors
Florida
$98.1K +$100K +13,500 New
GCP
96
GSA Capital Partners
United Kingdom
$88K +$89.5K +12,064 New
AB
97
Amalgamated Bank
New York
$87K -$19.8K -2,672 -18%
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$86K -$112K -15,063 -56%
CA
99
Claro Advisors
Massachusetts
$82.3K -$3.71K -500 -4%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$80.8K – – –
2 3
4
5 6

PNT Hedge Fund Activity: Q1 2023 in Review

115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q1 2023, worth a combined $455M — up 2.1% from $446M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PNT positions and 13 closed out — a net gain of 6 holders — while 34 added to existing stakes and 37 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $17.4M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $19.2M sold.

  • 115 institutional investors held POINT Biopharma Global Inc. Common Stock (PNT) as of Q1 2023, up from 109 in Q4 2022.
  • Funds reported $455M of POINT Biopharma Global Inc. Common Stock stock for Q1 2023, up 2.1% quarter-over-quarter.
  • 19 funds opened new POINT Biopharma Global Inc. Common Stock positions in Q1 2023 and 13 closed out, a net change of +6 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q1 2023 was Deep Track Capital, an estimated $17.4M added.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q1 2023 was Suvretta Capital Management, an estimated $19.2M sold.

Based on aggregated 13F filings for Q1 2023.